Karl Axel Staffan Eriksson
Fondatore presso Alertix Veterinary Diagnostics AB
Profilo
Karl Axel Staffan Eriksson is the founder of two companies.
He founded AroCell AB in 2003 and served as the Chief Scientific Officer from 2020 to 2021.
He also founded Alertix Veterinary Diagnostics AB in 2017 and currently holds the title of Director, Vice President-Research & Development.
Dr. Eriksson's former job was as a Professor at the Swedish University of Agricultural Sciences from 2000 to 2012.
Dr. Eriksson holds a doctorate degree from both Karolinska Institutet and the Swedish University of Agricultural Sciences.
Posizioni attive di Karl Axel Staffan Eriksson
| Società | Posizione | Inizio |
|---|---|---|
Alertix Veterinary Diagnostics AB
 Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Fondatore | 01/01/2017 |
Precedenti posizioni note di Karl Axel Staffan Eriksson
| Società | Posizione | Fine |
|---|---|---|
| AROCELL AB | Fondatore | 01/01/2020 |
| Swedish University of Agricultural Sciences | Corporate Officer/Principal | - |
Formazione di Karl Axel Staffan Eriksson
| Karolinska Institutet | Doctorate Degree |
| Swedish University of Agricultural Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Aziende private | 1 |
|---|---|
Alertix Veterinary Diagnostics AB
Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Karl Axel Staffan Eriksson
